| 1 |
32654232 | Isorhamnetin induces the paraptotic cell death through ROS and the ERK/MAPK pathway in OSCC cells. | 2021 Mar |
2 |
| 2 |
32602541 | Expression of Concern: Isorhamnetin inhibited migration and invasion via suppression of Akt/ERK-mediated epithelial-to-mesenchymal transition (EMT) in A549 human non-small cell lung cancer cells. | 2020 Jul 31 |
1 |
| 3 |
32766793 | Correction: Isorhamnetin inhibited migration and invasion via suppression of Akt/ERK-mediated epithelial-to-mesenchymal transition (EMT) in A549 human non-small cell lung cancer cells. | 2020 Aug 28 |
1 |
| 4 |
31467176 | Isorhamnetin inhibited migration and invasion via suppression of Akt/ERK-mediated epithelial-to-mesenchymal transition (EMT) in A549 human non-small-cell lung cancer cells. | 2019 Sep 30 |
1 |
| 5 |
30372904 | Isorhamnetin suppresses PANC-1 pancreatic cancer cell proliferation through S phase arrest. | 2018 Dec |
2 |
| 6 |
26359917 | Inhibitory Effects of Isorhamnetin on the Invasion of Human Breast Carcinoma Cells by Downregulating the Expression and Activity of Matrix Metalloproteinase-2/9. | 2015 |
2 |
| 7 |
21330379 | Isorhamnetin suppresses skin cancer through direct inhibition of MEK1 and PI3-K. | 2011 Apr |
2 |